CH3 BIOSYSTEMS LLC产品代理
CH3 BIOSYSTEMS LLC产品代理
该工具为探索蛋白质甲基化在生物系统中的重要性的研究提供了基本优势。
现在可从我们的目录中销售的其他产品和正在开发的其他产品旨在促进蛋白质甲基化生物医学分析的简单和快速发展。
为我们的客户、基础科学研究和临床实验室社区提供世界一流的高性能产品，用于发现细胞和组织中的蛋白质甲基化途径。
通过卓越的研究服务将我们的客户视为战略业务合作伙伴，以确保在蛋白质甲基化生物学领域的扩展中取得成功。
通过开发筛选技术来拓宽生物技术市场，以识别和商业化用于治疗癌症和神经发育障碍等疾病的药物和诊断候选药物。
Our flagship methylarginine-specific antibody, anti-mRG, is specifically designed to recognize the greatest number of methylproteins currently known. The immunizing antigen is based on a site of methylation found in a minimally required peptide sequence of consensus for arginine methylation.
This tool provides a fundamental advantage for research that is
exploring the importance of protein methylation in biological systems.
Additional products now available for sale from our catalog and others in development are designed to promote simple and rapid advance in the biomedical analysis of protein methylation.
To provide our customers, the Basic Science Research and Clinical Laboratory communities, with world-class, high-performance products for the discovery of protein methylation pathways in cells and tissues.
To treat our customers as strategic business partners through superior research services to ensure success in the expansion of the field of protein methylation biology.
To broaden the biotechnology market through development of screening technologies to identify and commercialize drug and diagnostic candidates for the treatment of diseases such as cancer and neuro-developmental disorders.
